MedTrace Logo

2010/2011 Trivalent Influenza Vaccination

NCT01304563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2011-02-25

No results posted yet for this study

Summary

Intradermal influenza vaccination may result in better efficacy when compare to intramuscular vaccination.

Conditions

Interventions

BIOLOGICAL

TIV 2010/2011 influenza vaccine

TIV 2010/2011 influenza vaccine Intramuscular: 15 mcg TIV 2010/2011 vaccine x 1: Control

BIOLOGICAL

TIV 2010/2011 influenza vaccine

Low dose TIV 2010/2011 influenza vaccine delivered via intradermal injection x 1: Experimental

BIOLOGICAL

TIV 2010/2011 influenza vaccine

Higher lower dose TIV 2010/2011 influenza vaccine delivered via intradermal injection x 1: Experimental

BIOLOGICAL

INT

Low dose TIV 2010/2011 influenza vaccine delivered via a short needle intradermal device x 1: Experimental

Sponsors & Collaborators

  • Hospital Authority, Hong Kong

    collaborator OTHER_GOV

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01304563 on ClinicalTrials.gov